Increased creativity associated with dopamine agonist therapy: A case report and short review of the literature
Impulse control disorder (ICD) has been linked to dopamine agonist use in patients with Parkinson's disease. Increased creativity is another cognitive side effect of dopaminergic therapy. While ICD is well recognized in the literature, enhanced creativity as a positive phenomenon is underreported because it does not negatively affect the patients' quality of life. Herein, we report a case of a 49-year-old man with Parkinson's disease who developed enhanced creativity expressed by the acquisition of multiple, new artistic skills with ropinirole treatment. He spent a significant amount of time on painting, carving and axe restoration, selling these artistic products became a source of income. He also reports that these hobbies help him cope with physical limitations caused by Parkinson's disease.
Clinical neurology and neurosurgery
Digital Object Identifier (DOI)
Thakolwiboon, Smathorn; Karukote, Amputch; Julayanont, Parunyou; and Wilms, Henrik, "Increased creativity associated with dopamine agonist therapy: A case report and short review of the literature" (2022). Neurology. 1237.